Structures by: El-Emary T. I.
Total: 12
3-(9<i>H</i>-Carbazol-9-yl)propanoic acid
C15H13NO2
IUCrData (2016) 1, 11 x161787
a=9.4550(5)Å b=11.9077(6)Å c=12.2120(7)Å
α=62.429(5)° β=79.276(4)° γ=77.627(4)°
6-Amino-3-methyl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyrazine-5-carboxamide
C13H12N6O
IUCrData (2016) 1, 11 x161742
a=14.7907(5)Å b=4.80351(15)Å c=17.1203(8)Å
α=90° β=92.067(4)° γ=90°
4-Amino-3-[2-(9<i>H</i>-carbazol-9-yl)ethyl]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione dimethyl sulfoxide monosolvate
C16H15N5S,C2H6OS
IUCrData (2016) 1, 11 x161855
a=14.7620(4)Å b=7.3509(2)Å c=17.9987(5)Å
α=90° β=106.9360(10)° γ=90°
3-[2-(9<i>H</i>-Carbazol-9-yl)ethyl]-4-phenyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione dimethyl sulfoxide monosolvate
C22H18N4S,C2H6OS
IUCrData (2016) 1, 11 x161835
a=5.89480(10)Å b=17.7215(4)Å c=22.0042(5)Å
α=90° β=90° γ=90°
(NZ)-N-[(1,3-diphenyl-1<i>H</i>-pyrazol-4-yl)methylidene]-N- oxidoanilinium
C22H17N3O
RSC Advances (2020) 10, 2 845-850
a=9.1084(8)Å b=10.8314(9)Å c=17.2226(14)Å
α=90° β=94.060(3)° γ=90°
3-Methyl-1-phenyl-5-(1<i>H</i>-pyrrol-1-yl)-1<i>H</i>-pyrazole-4-carbaldehyde
C15H13N3O
Acta Crystallographica Section E (2014) 70, 10 o1131-o1132
a=9.5807(8)Å b=15.1720(13)Å c=8.7370(8)Å
α=90° β=93.6180(11)° γ=90°
5-[2-(9<i>H</i>-carbazol-9-yl)ethyl]-1,3,4-oxadiazole-2(3<i>H</i>)-thione
C16H13N3OS
Acta Crystallographica Section E (2017) 73, 7 1066-1069
a=16.6868(5)Å b=4.96000(10)Å c=17.2353(6)Å
α=90° β=105.909(3)° γ=90°
<i>N</i>-[(8<i>E</i>)-12-Methyl-14-phenyl-10,13,14,16-tetraazatetracyclo[7.7.0.0^2,7^.0^11,15^]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-ylidene]hydroxylamine 1,4-dioxane hemisolvate
C19H13N5O,0.5(C4H8O2)
Acta Crystallographica Section E (2015) 71, 2 o75-o76
a=15.8019(4)Å b=5.56750(10)Å c=20.4756(5)Å
α=90° β=102.093(2)° γ=90°
Ethyl (2<i>Z</i>)-2-cyano-3-[(3-methyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)amino]prop-2-enoate
C16H16N4O2
Acta Crystallographica Section E (2014) 70, 11 o1214-o1215
a=9.0656(2)Å b=10.4085(3)Å c=16.5551(4)Å
α=86.9930(11)° β=81.5670(10)° γ=73.3900(11)°
(<i>E</i>)-<i>N</i>-{[3-Methyl-1-phenyl-5-(1<i>H</i>-pyrrol-1-yl)-1<i>H</i>-pyrazol-4-yl]methylidene}hydroxylamine
C15H14N4O
Acta Crystallographica Section E (2014) 70, 11 o1216-o1217
a=9.1497(2)Å b=12.3932(3)Å c=12.7294(3)Å
α=87.4070(11)° β=82.6740(12)° γ=75.0190(12)°
5-(4,5-Dihydro-1<i>H</i>-imidazol-2-yl)-3-methyl-1-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyrazin-6-amine
C15H15N7
Acta Crystallographica Section E (2014) 70, 11 o1212-o1213
a=7.9412(2)Å b=15.7078(3)Å c=22.3276(4)Å
α=90° β=98.5730(10)° γ=90°
3-(9<i>H</i>-Carbazol-9-yl)-<i>N</i>'-[(<i>E</i>)-4-chlorobenzylidene]propanohydrazide
C22H18ClN3O
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 12 o937-8
a=16.0126(7)Å b=7.4316(3)Å c=16.1654(9)Å
α=90° β=94.607(4)° γ=90°